Digital brain training for kids with sickle cell disease
Part of Blood & lymphatic, Genetic & congenital clinical trials.
This trial is testing a digital program to help improve working memory (the ability to hold and use information in your mind) for children with sickle cell disease. If you join, you'll use a computer-based training program at home and researchers will see if it works and is easy to use.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 7 and 16 years old.
- You have sickle cell disease (any type).
- You scored below average on a working memory test or have been told you have trouble with working memory.
- You can use a computer (no major problems with vision, hearing, or movement).
- You do not have a mental health condition that would interfere with the training.
- You have no history of seizures triggered by flashing lights.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a computer-based “attention control” training program can improve attention and daily functioning in children with sickle cell disease. To join, you must meet certain criteria and also pass an initial attention screening test during the study.
This Phase 2 study tests a cognitive (thinking) training program to help teens with sickle cell disease prepare for the changes in their care as they grow older. It may help with skills like learning, attention, and planning for transition to adult care.
This study tests whether a common medication called methylphenidate (often used for ADHD) can help children with sickle cell disease who have attention or memory problems. If the child qualifies, the study may offer a new way to improve focus and daily functioning.
This study uses MRI scans to understand how the brain and blood vessels are affected in children with sickle cell disease, including before and after certain treatments. It also includes healthy children for comparison and may help improve future monitoring and care.
This trial tests a light-based therapy called transcranial photobiomodulation to see if it can help people with sickle cell disease. It is for children and teens aged 8 to 17 who are part of the SCCRIP study and have not had certain brain complications.
This trial tests a mobile app to help people with sickle cell disease manage their health. It's designed for those who have a compatible smartphone and internet access.
Hear when a new Sickle Cell Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.